Study: Drug cocktail improves survival of mice with bird flu

06/2/2008 | Reuters

Treatment with zanamivir -- an antiviral drug -- combined with celecoxib and mesalazine -- nonsteroidal anti-inflammatory agents -- reduced an overreaction of the immune system and improved the survival rates of mice injected with fatal doses of the H5N1 avian flu virus, scientists in Hong Kong found. Clinical trials of the three drugs should be conducted because the drugs might prove effective in humans and "decrease the mortality rate to 20%, theoretically," one of the researchers said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ